Iron oxide nanoparticles (IONPs) have emerged as a promising alternative to conventional
contrast agents (CAs) for magnetic resonance imaging (MRI). They have been extensively …

The field of nanomedicine has recently emerged as a product of the expansion of a range of
nanotechnologies into biomedical science, pharmacology and clinical practice. Due to the …

Introduction In the field of drug delivery, controlling the release of therapeutic substances at
localized targets has become a primary focus of medical research, especially in the field of …

In a report from 2008, The International Agency for Research on Cancer predicted a tripled
cancer incidence from 1975, projecting a possible 13-17 million cancer deaths worldwide by …

Introduction: Today, the development of multifunctional nanoplatforms is more seriously
considered in the field of cancer theranostics. Areas covered: In this respect, nanoparticles …

Magnetic nanoparticles (MNPs) represent a class of non-invasive imaging agents that have
been developed for magnetic resonance (MR) imaging. These MNPs have traditionally been …

The use of magnetic nanoparticles for sensing and theranostics of cancer has grown
substantially in the last decade. Since the pioneering studies, which reported magnetic …

Nanotechnology holds a promising potential for developing biomedical nanoplatforms in
cancer therapy. The magnetic nanoparticles, which integrate uniquely appealing features of …

Engineering and functionalizing magnetic nanoparticles have been an area of the extensive
research and development in the biomedical and nanomedicine fields. Because their …

Engineered magnetic nanoparticles (MNPs) represent a cutting-edge tool in medicine
because they can be simultaneously functionalized and guided by a magnetic field. Use of …